Thanks Chelseadude65.
I'm aware that first patient dosage was specified as before Q1 of 2024 - meaning end of March. I'm more interested in when could we expect the results of the phase 2 trial. For clarity, efficacy data.
I don't remember this ever being stated when I was reading through the company presentations and announcements .
Thanks Chelseadude65. I'm aware that first patient dosage was...
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
74.5¢ |
Change
0.025(3.47%) |
Mkt cap ! $92.11M | |||
| Open | High | Low | Value | Volume |
| 71.0¢ | 76.0¢ | 71.0¢ | $271.4K | 363.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13500 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.5¢ | 5800 | 2 |
View Market Depth
| Last trade - 11.35am 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
75.0¢ |
Change
0.025 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 73.0¢ | 75.5¢ | 73.0¢ | 97519 | ||
| Last updated 12.04pm 21/05/2024 ? | |||||
| AGN (ASX) Chart |